US Broker Ratings

Humana Inc. (HUM) Stock Analysis: Navigating Growth in the Healthcare Plans Sector

As an integral player in the healthcare plans industry, Humana Inc. (NYSE: HUM) continues to captivate investor interest with its expansive portfolio and strategic positioning in the U.S. healthcare market...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Capitalizing on a 14.39% Potential Upside

Investors eyeing the healthcare sector may want to keep a close watch on Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company renowned for its innovative enzyme technologies. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: A 135% Upside Potential in Revolutionary Cancer Therapies

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its remarkable potential in the biotechnology sector, particularly in the realm of oncology treatments. Despite its relatively modest..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating the Highs with a 73.7% Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, is capturing the attention of investors with its impressive financial metrics and strategic positioning in the diagnostics and..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Frontier with a Market Cap of $15.5 Billion

Tempus AI, Inc. (NASDAQ: TEM) is carving a niche in the healthcare technology sector, with its innovative approach to health information services. The company, headquartered in Chicago, Illinois, stands out..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Giant with a 24.74% Potential Upside Awaits Investor Attention

Ascendis Pharma A/S (NASDAQ: ASND), a key player in the biotechnology sector, continues to capture the interest of investors with its innovative approach to treating unmet medical needs. Headquartered in..

Revolution Medicines, Inc. (RVMD) Investor Outlook: A Promising 41.72% Upside Potential Amidst Strong Buy Consensus

Revolution Medicines, Inc. (NASDAQ: RVMD) is garnering significant attention from investors, particularly those with an eye for high-growth potential in the biotechnology sector. Specializing in precision oncology, this U.S.-based company..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 7.34% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a key player in the healthcare sector specializing in diagnostics and research, continues to capture the attention of investors with its robust market presence and..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Evaluating 2.30% Upside Amid Healthcare Sector Dynamics

Smith & Nephew SNATS, Inc. (SNN), a stalwart in the healthcare sector, continues to capture the attention of investors as it navigates the complex medical devices industry. With a market..

Chemed Corp (CHE) Stock Analysis: Exploring a 32.5% Potential Upside and Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Chemed Corp (NYSE: CHE) presents a compelling case. The company, headquartered in Cincinnati, Ohio, is a significant player in the medical care..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 25% Upside with Robust Analyst Support

Alcon Inc. (NYSE: ALC), a leading player in the global eye care industry, offers a compelling investment opportunity with a potential upside of 25.04%, according to analyst ratings. With a..

Verona Pharma plc (VRNA) Stock Analysis: A Healthcare Contender at Its 52-Week High

Verona Pharma plc (NASDAQ: VRNA) has captured investor attention as it recently hit its 52-week high of $106.91, marking a significant milestone for this UK-based biopharmaceutical company. Specializing in the..

DexCom, Inc. (DXCM) Investor Outlook: Key Insights on a 39.91% Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego,..

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Gem with 8.42% Upside Potential

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector as a dynamic player in the medical instruments and supplies industry. With a market capitalization of $9.36 billion, the company..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 28.61% Potential Upside in Animal Health

Zoetis Inc. (NYSE: ZTS), a prominent player in the animal health industry, presents a compelling proposition for investors seeking growth opportunities within the healthcare sector. As the largest pure-play animal..

BioNTech SE (BNTX) Stock Analysis: A 27.62% Potential Upside Amid Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a pivotal player in the biotechnology sector, is drawing significant investor attention with its notable 27.62% potential upside, as suggested by the average analyst target price..

Align Technology, Inc. (ALGN) Stock Analysis: Evaluating a 29% Potential Upside in Healthcare Innovation

Align Technology, Inc. (NASDAQ: ALGN) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies. Headquartered in Tempe, Arizona, Align Technology is renowned for its..

Eli Lilly and Company (LLY) Stock Analysis: Navigating a $739.98 Billion Market Cap with Impressive Revenue Growth

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, is making waves with its impressive market capitalization of $739.98 billion. Operating within the Drug Manufacturers – General..

Natera, Inc. (NTRA) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Natera, Inc. (NASDAQ: NTRA) is making significant strides in the healthcare sector, specifically in diagnostics and research. As a frontrunner in molecular testing services, Natera’s innovative product lineup, including the..

Masimo Corporation (MASI) Stock Analysis: Exploring a 26.93% Potential Upside in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, has caught the attention of investors with its substantial potential upside of 26.93%. As a medical device manufacturer headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds